abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis
Company Description
abrdn Life Sciences Investors (NYSE: HQL) is classified in the asset management industry within the Financial Services sector and carries a market capitalization of $627.0M, ranking #3,424 among all listed U.S. companies by market cap.
HQL has gained 55.5% over the past year. Shares last traded at $20.62.
This page collects what Stock Titan holds for HQL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
abrdn Life Sciences Investors (HQL) stock last closed at $20.62. Over the past 12 months, the stock has gained 55.5%. At a market capitalization of $627.0M, HQL is classified as a small-cap stock.
HQL Rankings
Latest News
abrdn Life Sciences Investors has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include buybacks. View all HQL news →
SEC Filings
abrdn Life Sciences Investors has filed 5 recent SEC filings, including 2 Form SCHEDULE 13D/A, 1 Form 3, 1 Form 4, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on July 20, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HQL SEC filings →
Insider Radar
Insider buying activity at abrdn Life Sciences Investors over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Short Interest History
Short interest in abrdn Life Sciences Investors (HQL) currently stands at 62.7 thousand shares, up 339.8% from the previous reporting period, representing 0.2% of the shares outstanding. Since August 2025, short interest has increased by 103.5%.
Days to Cover History
Days to cover for abrdn Life Sciences Investors (HQL) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
HQL Company Profile & Sector Positioning
abrdn Life Sciences Investors (HQL) operates in the Asset Management industry within the broader Financial Services sector and is listed on the NYSE.
Investors comparing HQL often look at related companies in the same sector, including BlackRock Health Sciences Trust (BME), BlackRock MuniVest (MVF), abrdn World Healthcare Fund (THW), Palmer Square Capital Bdc Inc. (PSBD), and First Trust Enhanced Equity Income Fund (FFA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HQL's relative position within its industry.